The Study of Regional Lung Ventilation-perfusion by EIT
1 other identifier
observational
100
1 country
1
Brief Summary
This is a prospective observational trial. The purpose of this study is to explore the feasibility of EIT monitoring pulmonary blood flow and the consistency and difference between EIT monitoring pulmonary local ventilation blood flow and SPECT and CTPA monitoring methods
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
January 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedNovember 3, 2021
October 1, 2021
3.4 years
January 28, 2021
October 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Regional pulmonary perfusion by EIT
Using EIT to measure the regional pulmonary perfusion and calculate ventilation/perfusion ratio
1 Day
Regional pulmonary perfusion by CTPA
Using CTPA to measure the regional pulmonary perfusion and calculate ventilation/perfusion ratio
1 Day
Secondary Outcomes (1)
Regional pulmonary ventilation index by EIT
1 Day
Study Arms (2)
EIT group
patients went through EIT detection
CTPA group
patients went through CTPA detection
Eligibility Criteria
Patients who need CTPA examination in the Department of nuclear medicine / radiology of Peking Union Medical College Hospital
You may qualify if:
- Admission to ICU was less than 72 hours;
- Age ≥ 18 years old and ≤ 80 years old;
- Volunteer to participate after communicating with patients' family members;
You may not qualify if:
- The patients with heart implants could not be monitored by EIT;
- Patients or their families refused to participate in the study;
- Hypernatremia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Study Officials
- STUDY DIRECTOR
Yun Long
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2021
First Posted
November 3, 2021
Study Start
January 1, 2020
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
November 3, 2021
Record last verified: 2021-10